Skip to main content
Equibles
OMER logo

OMER · Omeros Corp

Track OMER — free

Use OMER with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about OMER

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$17.19 -0.16 (-0.92%) At close · Aug 14
Market Cap
$1.24B
Shares
72.39M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-08-12 Omeros Corporation Reports Second Quarter 2026 Financial Results
2026-08-10 Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026
2026-08-03 CMS Grants New Technology Add-On Payment (NTAP) Status to YARTEMLEA®
2026-06-26 Omeros Corporation Announces Update on European Marketing Authorization Application for Narsoplimab in TA-TMA
2026-06-15 Omeros Announces Webcast Details for Annual Meeting of Shareholders
2026-05-13 Omeros Corporation Reports First Quarter 2026 Financial Results
2026-05-11 Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026
2026-04-16 CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA® (narsoplimab-wuug)
2026-03-31 Omeros Corporation Reports Fourth Quarter and Year-End 2025 Financial Results
2026-03-26 Omeros Corporation to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 31, 2026
2026-03-21 Omeros Announces Upcoming Presentation at EBMT 2026 Highlighting Advances in TA-TMA Treatment
2026-02-17 Omeros Announces Successful Primate Study in OncotoX-AML™ Drug Program
2026-01-27 Omeros Announces First Commercial Sales of YARTEMLEA®
2025-12-26 Omeros Announces New Date for YARTEMLEA® Approval Conference Call

Past events

Date Event Type
2026-08-12 Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026 Earnings call
2026-08-12 Omeros Corporation Q2 2026 Earnings Conference Call Earnings call
2026-06-18 2026 Omeros Corporation Virtual Annual Meeting of Shareholders Shareholder meeting
2026-05-13 Omeros Corporation Q1 2026 Earnings Conference Call Earnings call
2026-03-31 Q4 2025 Omeros Corporation Earnings Conference Call Earnings call
2026-01-07 Earnings conference call (announced in 8-K) Earnings call
2025-11-13 Q3 2025 Omeros Corporation Earnings Conference Call Earnings call
2025-08-14 Q2 2025 Omeros Corporation Earnings Conference Call Earnings call
2025-06-27 Omeros Corporation Virtual Annual Meeting of Shareholders Shareholder meeting
2025-05-15 Q1 2025 Omeros Corporation Earnings Conference Call Earnings call
2025-03-31 Q4 2024 Omeros Corporation Earnings Conference Call Earnings call
2024-11-13 Q3 2024 Omeros Corporation Earnings Conference Call Earnings call
2024-08-07 Q2 2024 Omeros Corporation Earnings Conference Call Earnings call
2024-06-06 Omeros Corporation Virtual Annual Shareholder Meeting Shareholder meeting
2024-05-15 Q1 2024 Omeros Corporation Earnings Conference Call Earnings call
2024-04-01 Q4 2023 Omeros Corporation Earnings Conference Call Earnings call

Source: https://investor.omeros.com/overview/default.aspx

Key facts CIK 1285819 CUSIP 682143102 13F (30d) 174 filings 167 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)